SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    't Hart BA, Bauer J, Muller HJ, Melchers B, Nicolay K, Brok H, Bontrop RE, Lassmann H, Massacesi L. Histopathological characterization of magnetic resonance imaging- detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am. J. Pathol. 1998; 153: 649663.
  • 2
    't Hart BA, Laman JD, Bauer J, Blezer EL, Van Kooyk Y, Hintzen RQ. Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol. 2004; 3: 588597.
  • 3
    Antunes SG, de Groot NG, Brok H, Doxiadis G, Menezes AA, Otting N, Bontrop RE. The common marmoset: a new world primate species with limited Mhc class II variability. Proc. Natl. Acad. Sci. USA 1998; 95: 1174511750.
  • 4
    Brok HP, Uccelli A, Kerlero DR, Bontrop RE, Roccatagliata L, de Groot NG, Capello E, Laman JD, Nicolay K, Mancardi GL, Ben Nun A, 't Hart BA. Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24–36 is presented by a monomorphic MHC Class II molecule. J. Immunol. 2000; 165: 10931101.
  • 5
    't Hart BA, Vogels J, Bauer J, Brok HP, Blezer EL. Non-invasive measurement of brain damage in a primate model of multiple sclerosis. Trends. Mol. Med. 2004; 10: 8591.
  • 6
    't Hart BA, Brok HP, Remarque E, Benson J, Treacy G, Amor S, Hintzen RQ, Laman JD, Bauer J, Blezer EL. Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human–anti-human IL-12p40 antibody. J. Immunol. 2005; 175: 47614768.
  • 7
    't Hart BA, Blezer EL, Brok HP, Boon L, de Boer M, Bauer J, Laman JD. Treatment with chimeric anti-human CD40 antibody suppresses MRI-detectable inflammation and enlargement of pre-existing brain lesions in common marmosets affected by MOG-induced EAE. J. Neuroimmunol. 2005; 163: 3139.
  • 8
    Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez-Scarano F, Lavi E, Cohen JA. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992; 182: 483491.
  • 9
    Larsson HB, Frederiksen J, Petersen J, Nordenbo A, Zeeberg I, Henriksen O, Olesen J. Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn. Reson. Med. 1989; 11: 337348.
  • 10
    Larsson HB, Christiansen P, Zeeberg I, Henriksen O. In vivo evaluation of the reproducibility of T1 and T2 measured in the brain of patients with multiple sclerosis. Magn. Reson. Imag. 1992; 10: 579584.
  • 11
    Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 1999; 12: 295302.
  • 12
    Bruck W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 1995; 38: 788796.
  • 13
    Haase A. Snapshot FLASH MRI. Applications to T1, T2, and chemical-shift imaging. Magn. Reson. Med. 1990; 13: 7789.
  • 14
    Stephan H, Baron G, Schwerdtfeger WK. The Brain of the Common Marmoset (Callithrix Jacchus). A Stereotaxic Atlas. Springer: Berlin, 1980.
  • 15
    't Hart BA, Amor S, Jonker M. Evaluating the validity of animal models for research into therapies for immune-based disorders. Drug Discov. Today 2004; 9: 517524.
  • 16
    Boon L, Brok HP, Bauer J, Ortiz-Buijsse A, Schellekens MM, Ramdien-Murli S, Blezer EL, van Meurs M, Ceuppens J, de Boer M, 't Hart BA, Laman JD. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J. Immunol. 2001; 167: 29422949.
  • 17
    Brok HP, van Meurs M, Blezer EL, Schantz A, Peritt D, Treacy G, Laman JD, Bauer J, 't Hart BA. Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody. J. Immunol. 2002; 169: 65546563.
  • 18
    Jordan EK, McFarland HI, Lewis BK, Tresser N, Gates MA, Johnson M, Lenardo M, Matis LA, McFarland HF, Frank JA. Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset. Am. J. Neuroradiol. 1999; 20: 965976.
  • 19
    Willoughby EW, Grochowski E, Li DK, Oger J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann. Neurol. 1989; 25: 4349.
  • 20
    Larsson HB, Frederiksen J, Kjaer L, Henriksen O, Olesen J. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn. Reson. Med. 1988; 7: 4355.
  • 21
    Ormerod IE, Bronstein A, Rudge P, Johnson G, MacManus D, Halliday AM, Barratt H, du BE, Kendal BE, Moseley IF. Magnetic resonance imaging in clinically isolated lesions of the brain stem. J. Neurol. Neurosurg. 1986; 49: 737743.
  • 22
    Claudio L, Kress Y, Factor J, Brosnan CF. Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells. Am. J. Pathol. 1990; 137: 10331045.
  • 23
    Barnes D, McDonald WI, Johnson G, Tofts PS, Landon DN. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J. Neurol. Neurosurg. Psychiat. 1987; 50: 125133.
  • 24
    MacKay A, Whittall K, Adler J, Li D, Paty D, Graeb D. In vivo visualization of myelin water in brain by magnetic resonance. Magn. Reson. Med. 1994; 31: 673677.
  • 25
    Barnes D, McDonald WI, Landon DN, Johnson G. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain 1988; 111: 8394.
  • 26
    Filippi M, Rocca MA, Sormani MP, Pereira C, Comi G. Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging. Magn. Reson. Imag. 1999; 17: 979984.
  • 27
    Dousset V, Gayou A, Brochet B, Caille JM. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Magn. Reson. Med. 1998; 51: 11501155.
  • 28
    Campi A, Filippi M, Comi G, Scotti G, Gerevini S, Dousset V. Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis. Neuroradiology 1996; 38: 115119.
  • 29
    Gareau PJ, Rutt BK, Karlik SJ, Mitchell JR. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J. Magn. Reson. Imag. 2000; 11: 586595.
  • 30
    Harris JO, Frank JA, Patronas N, McFarlin DE, McFarland HF. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann. Neurol. 1991; 29: 548555.
  • 31
    He J, Grossman RI, Ge Y, Mannon LJ. Enhancing patterns in multiple sclerosis: evolution and persistence. Am. J. Neuroradiol. 2001; 22: 664669.
  • 32
    Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 1997; 42: 783793.
  • 33
    Strich G, Hagan PL, Gerber KH, Slutsky RA. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA. Radiology 1985; 154: 723726.
  • 34
    Brochet B, Dousset V. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Magn. Reson. Med. 1999; 53: S12S17.
  • 35
    Cook LL, Foster PJ, Mitchell JR, Karlik SJ. In vivo 4.0-T magnetic resonance investigation of spinal cord inflammation, demyelination, and axonal damage in chronic-progressive experimental allergic encephalomyelitis. J. Magn. Reson. Imag. 2004; 20: 563571.
  • 36
    van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, Lycklama a Nijeholt GJ, van der Valk P, Polman CH, Thompson AJ, Barkhof F. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 1999; 46: 747754.
  • 37
    Morrissey SP, Stodal H, Zettl U, Simonis C, Jung S, Kiefer R, Lassmann H, Hartung HP, Haase A, Toyka KV. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 1996; 119: 239248.
  • 38
    Seeldrayers PA, Syha J, Morrissey SP, Stodal H, Vass K, Jung S, Gneiting T, Lassmann H, Haase A, Hartung HP. Magnetic resonance imaging investigation of blood–brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1993; 46: 199206.
  • 39
    Floris S, Blezer EL, Schreibelt G, Dopp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE. Blood–brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 2004; 127: 616627.
  • 40
    Hawkins CP, Munro PM, MacKenzie F, Kesselring J, Tofts PS, du BE, Landon DN, McDonald WI. Duration and selectivity of blood–brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990; 113: 365378.
  • 41
    Karlik SJ, Munoz D, St.Louis J, Strejan G. Correlation between MRI and clinico pathological manifestations in Lewis rats protected from experimental allergic encephalomyelitis by acylated synthetic peptide of myelin basic protein. Magn. Reson. Imag. 1999; 17: 731737.
  • 42
    Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann. Neurol. 1993; 34: 661669.
  • 43
    Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991; 180: 467474.
  • 44
    van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, Valk J, Polman CH, Barkhof F. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Magn. Reson. Med. 1998; 50: 12821288.
  • 45
    Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann. Neurol. 2001; 49: 793796.
  • 46
    Tovi M, Ericsson A. Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol. 1992; 33: 400404.
  • 47
    Nijeholt GJ, Bergers E, Kamphorst W, Bot J, Nicolay K, Castelijns JA, van Waesberghe JH, Ravid R, Polman CH, Barkhof F. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 2001; 124: 154166.
  • 48
    Bot JC, Blezer EL, Kamphorst W, Lycklama ANG, Ader HJ, Castelijns JA, Ig KN, Bergers E, Ravid R, Polman C, Barkhof F. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 2004; 233: 531540.